Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 4/20 | 0.71 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.65 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | KDM1A | O60341 | 3/20 | 0.54 |
| ▸ | MAOA | P21397 | 3/20 | 0.54 |
| ▸ | MAOB | P27338 | 2/20 | 0.54 |
| ▸ | RCOR1 | Q9UKL0 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.51 |
| ▸ | BLK | P51451 | 1/20 | 0.50 |
| ▸ | BTK | Q06187 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3794371 | 0.91 | MGLL (0.82) | MGLLENPP2POLBTP53MAPT | |
| SCHEMBL3790408 | 0.89 | MGLL (0.70) | MGLLENPP2POLBTP53MAPT | |
| SCHEMBL3784570 | 0.88 | ROCK2 (0.66) | MGLLENPP2ROCK2POLBTP53 | |
| SCHEMBL3789318 | 0.87 | MGLL (0.85) | MGLLENPP2ROCK2POLBTP53 | |
| SCHEMBL3784563 | 0.85 | MGLL (0.62) | MGLLENPP2ROCK2POLBTP53 | |
| SCHEMBL3780622 | 0.85 | MGLL (0.62) | MGLLENPP2ROCK2POLBTP53 | |
| SCHEMBL3583048 | 0.85 | MGLL (0.72) | MGLLENPP2POLBTP53MAPT | |
| SCHEMBL3790375 | 0.85 | HDAC1 (0.67) | MGLLENPP2NPC1RAB9AHDAC1 | |
| SCHEMBL3785606 | 0.85 | MGLL (0.57) | MGLLENPP2POLBMAOBNPC1 | |
| SCHEMBL3784028 | 0.84 | MGLL (0.71) | MGLLENPP2ROCK2POLBTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1914221-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2008-04-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087680-A1 | METHOD FOR PRODUCING BIARYL COMPOUND | NISCH, BLVRB, BBOX1 | MGLL 1314/4885ENPP2 1920/4885ROCK2 2432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.